tiprankstipranks
Trending News
More News >
Crescent Biopharma (CBIO)
NASDAQ:CBIO
US Market

Crescent Biopharma (CBIO) Ownership - Who Owns Crescent Biopharma?

Compare
1,005 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 08, 2025
xxxxxxxxxxxxx
$18237600

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,747,866Insider9.97%34,705,548
1,387,866Institution5.04%17,528,748
596,777Institution2.17%7,537,294
595,515Institution2.16%7,521,354
453,686Institution1.65%5,730,054
323,517Insider1.17%4,086,020
305,040Institution1.11%3,852,655
302,457Institution1.10%3,820,032
159,707Insider0.58%2,017,099
75,614Institution0.27%955,005

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
596,777Institution2.17%7,537,294
305,040Institution1.11%3,852,655
9,119Institution0.03%115,173
8,416Institution0.03%106,294
8,006Institution0.03%101,116
6,332Institution0.02%79,973
6,254Institution0.02%78,988

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
513,579Institution1.86%7,729,364
81,936Institution0.30%1,233,137
548Institution<0.01%6,055

FAQ

Who Owns Crescent Biopharma (CBIO)?
Currently, no data Available
What percentage of Crescent Biopharma (CBIO) stock is held by institutional investors?
Currently, no data Available
What percentage of Crescent Biopharma (CBIO) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Crescent Biopharma (CBIO)?
Fairmount Funds Management LLC owns the most shares of Crescent Biopharma (CBIO).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.